Impact of Raltegravir on HIV-1 cDNA Slope Following Antiretroviral Therapy (ART) Initiation
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to HIV-1
Related studies linked through entity extraction aliases.
Dermal HIV-1 Immunization During Anti-retroviral Therapy Followed by Repeated Treatment Interruptions
- Status
- COMPLETED
- Phase
- PHASE1
Investigation of the Safety of an HIV-1 Vaccine Given Intra-muscularly and Intra-nasally to Healthy Female Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Immunogenicity of MVA.HIVconsv in HIV-1 Seropositive Adults on HAART
- Status
- TERMINATED
- Phase
- PHASE1
Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1/2-uninfected Mothers
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1-infected Mothers
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
TMC125-TiDP35-C239 - Continued Access to Etravirine (ETR) in Treatment Experienced HIV-1 Infected Participants
- Status
- COMPLETED
- Phase
- PHASE3
Genotypic Resistant HIV Strains in Taiwan
- Status
- UNKNOWN
- Phase
- N/A
Treatment De-Intensification and Residual HIV-1 in Youth
- Status
- COMPLETED
- Phase
- N/A
Non-Interventional Study Of Celsentri® In Treatment Experienced Patients With CCR5-Tropic HIV-Infection
- Status
- COMPLETED
- Phase
- N/A
A Worldwide, Phase I, Dose-Escalating Study of a 3-Dose Regimen of the MRKAd5 (Clade B) Vaccine in Healthy Adults (V520-018)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Safety, Tolerability, and Immunogenicity of the MRKAd5 Gag/Pol/Nef Vaccine in Healthy Adults (V520-016)
- Status
- COMPLETED
- Phase
- PHASE1
A Comparison of Virco®TYPE HIV-1 Testing Versus Expert Interpretation of Genotypic Results for Control of HIV-1 Replication
- Status
- UNKNOWN
- Phase
- PHASE4
PEPI-TiDP23-C103: First-in-Human Study to Examine the Safety, Tolerability, and Plasma Pharmacokinetics of Increasing Single and Repeated Oral Doses of TMC558445 and of a Combined Single Day Dosing of Oral TMC558445 and Oral TMC310911 and Also Oral Darunavir
- Status
- COMPLETED
- Phase
- PHASE1
A Study Of Different Doses Of UK-453, 061 Plus Truvada Compared To Efavirenz Plus Truvada In Patients Who Have Not Been Previously Treated For HIV-1
- Status
- COMPLETED
- Phase
- PHASE2
A Rollover Study For Subjects Discontinuing From UK-453,061 Studies For The Treatment Of HIV-1
- Status
- TERMINATED
- Phase
- PHASE2
A Phase 2B Multicenter, Randomized, Comparative Trial Of UK-453,061 Versus Etravirine In Combination With Darunavir/Ritonavir And A Nucleos(t)Ide Reverse Transcriptase Inhibitor For The Treatment Of Antiretroviral Experienced HIV-1 Infected Subjects With Evidence Of NNRTI Resistant HIV-1
- Status
- TERMINATED
- Phase
- PHASE2
TMC278-TiDP38-C145: A Bioavailability Study in Healthy Adult Volunteers to Evaluate 3 Pediatric Formulations of TMC278 (a Solution, a Suspension, and Granules) Compared to an Adult Tablet Formulation
- Status
- COMPLETED
- Phase
- PHASE1
Effect Of An Integrase Inhibitor On The Latency And Reservoir Of HIV-1
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Activity of Rilpivirine (TMC278) in Human Immunodeficiency Virus Infected Adolescents and Children Aged Greater Than or Equal to 6 Years
- Status
- COMPLETED
- Phase
- PHASE2